Get the Stockscreener App
27.81
0.38%
0.105
After Hours:
27.27
-0.54
-1.94%
Beta Bionics Inc stock is traded at $27.81, with a volume of 549.01K.
It is up +0.38% in the last 24 hours and up +24.93% over the past month.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
See More
Previous Close:
$27.70
Open:
$27.5
24h Volume:
549.01K
Relative Volume:
0.69
Market Cap:
$1.21B
Revenue:
$78.02M
Net Income/Loss:
$-73.37M
P/E Ratio:
-21.07
EPS:
-1.32
Net Cash Flow:
$-62.06M
1W Performance:
+14.54%
1M Performance:
+24.93%
6M Performance:
+135.08%
1Y Performance:
+0.00%
1-Day Range:
$26.51
$28.01
1-Week Range:
$26.00
$30.47
52-Week Range:
$8.89
$30.47
Beta Bionics Inc Stock (BBNX) Company Profile
Name
Beta Bionics Inc
Sector
Industry
Phone
949-427-7785
Address
11 HUGHES, IRVINE
Compare BBNX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
27.81 | 1.22B | 78.02M | -73.37M | -62.06M | -1.32 |
|
ABT
Abbott Laboratories
|
125.80 | 215.34B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.84 | 146.15B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
362.61 | 136.97B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.42 | 115.69B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
84.15 | 48.77B | 5.88B | 1.34B | 577.90M | 2.3455 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-21-25 | Resumed | Stifel | Buy |
| Oct-01-25 | Upgrade | Goldman | Neutral → Buy |
| Jun-16-25 | Initiated | Truist | Buy |
| Jun-12-25 | Initiated | Lake Street | Buy |
| May-30-25 | Initiated | Goldman | Neutral |
| May-30-25 | Initiated | Wolfe Research | Outperform |
| Feb-24-25 | Initiated | BofA Securities | Buy |
| Feb-24-25 | Initiated | Lake Street | Buy |
| Feb-24-25 | Initiated | Leerink Partners | Outperform |
| Feb-24-25 | Initiated | Piper Sandler | Overweight |
| Feb-24-25 | Initiated | Stifel | Buy |
| Feb-20-25 | Initiated | Ladenburg Thalmann | Neutral |
| Feb-20-25 | Initiated | Robert W. Baird | Neutral |
View All
Beta Bionics Inc Stock (BBNX) Latest News
Regression analysis insights on Beta Bionics Inc. performancePrice Action & Fast Gaining Stock Reports - newser.com
How supply chain issues affect Beta Bionics Inc. stockPortfolio Risk Summary & Technical Pattern Based Buy Signals - newser.com
Is Beta Bionics Inc. stock attractive for retirement portfoliosWeekly Earnings Recap & Real-Time Stock Price Movement Reports - newser.com
Is Beta Bionics Inc. stock positioned for long term growthMarket Growth Report & Daily Market Momentum Tracking - newser.com
Beta Bionics Announces Participation at Upcoming Investor Conferences - The Manila Times
Beta Bionics (BBNX) Q3 2025 Earnings Transcript - AOL.com
Beta Bionics Inc. (BBNX.US): Solid 3Q’25 Results But Valuation Full at Current Levels - Smartkarma
Will Beta Bionics Inc. price bounce be sustainableJuly 2025 Catalysts & Detailed Earnings Play Strategies - newser.com
Beta Bionics Inc. stock chart pattern explained2025 Top Gainers & Scalable Portfolio Growth Methods - newser.com
Is now a turning point for Beta Bionics Inc.Gap Down & Verified Stock Trade Ideas - newser.com
What drives Beta Bionics Inc stock priceMean Reversion Trades & Rapid Portfolio Appreciation - earlytimes.in
Analyzing Beta Bionics Inc. with multi timeframe chartsIPO Watch & Target Return Focused Picks - newser.com
Will Beta Bionics Inc. continue its uptrendJuly 2025 Pullbacks & Low Drawdown Investment Strategies - newser.com
Will a bounce in Beta Bionics Inc. offer an exitJuly 2025 Setups & Verified Momentum Stock Watchlist - newser.com
Beta Bionics, Inc. (NASDAQ:BBNX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Beta Bionics, Inc. (NASDAQ:BBNX) Sees Significant Drop in Short Interest - MarketBeat
Beta Bionics (NASDAQ:BBNX) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
Leerink Partnrs Predicts Higher Earnings for Beta Bionics - MarketBeat
Beta Bionics, Inc. (BBNX) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Beta Bionics raises 2025 revenue guidance to $96.5M and projects Q4 gross margin improvement amid pharmacy channel expansion - MSN
Beta Bionics, Inc. (BBNX) Reports Q3 Earnings: What Key Metrics Have to Say - MSN
Comparing Beta Bionics Inc. in custom built stock radarsJuly 2025 Analyst Calls & Verified Momentum Stock Ideas - newser.com
Published on: 2025-10-31 02:01:27 - newser.com
Midday Stock Roundup: BJ’s Surges After Earnings top Estimates - Orange County Business Journal
Beta Bionics Inc (BBNX) Q3 2025 Earnings Call Highlights: Record Growth and Strategic Challenges By GuruFocus - Investing.com Canada
Beta Bionics Reports Strong Q3 Growth and Raises Guidance - MSN
Beta Bionics (BBNX) Valuation Concerns Mount as Forecast Revenue Growth Far Exceeds Market Average - Yahoo Finance
Beta Bionics Reports Strong Q3 Growth Amid Challenges - MSN
Beta Bionics' (BBNX) "Overweight" Rating Reaffirmed at Piper Sandler - MarketBeat
Beta Bionics (NASDAQ:BBNX) Reaches New 1-Year High After Earnings Beat - MarketBeat
Beta Bionics’ iLet Experience Study: A Game-Changer in Diabetes Management? - MSN
Beta Bionics, Inc. (NASDAQ:BBNX) Released Earnings Last Week And Analysts Lifted Their Price Target To US$28.10 - Yahoo Finance
Beta Bionics, Inc. (NASDAQ:BBNX) Stocks Shoot Up 35% But Its P/S Still Looks Reasonable - 富途牛牛
BBNX Crosses Above Average Analyst Target - Nasdaq
Beta Bionics, Inc. (NASDAQ:BBNX) Looks Just Right With A 35% Price Jump - simplywall.st
Stifel Reiterates Beta Bionics (BBNX) Buy Recommendation - Nasdaq
Beta Bionics (NASDAQ:BBNX) Releases Earnings Results - MarketBeat
Truist Raises Price Target on Beta Bionics to $32 From $28, Keeps Buy Rating - MarketScreener
Beta Bionics price target raised to $31 from $26 at Stifel - TipRanks
Beta Bionics, Inc.Common Stock (NQ: BBNX - FinancialContent
Beta Bionics Inc Stock (BBNX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.47%
0.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):